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The past 15 years have seen the development of a field
in immunology entirely devoted to understanding the
divergence of CD4+ T cells into distinct cytokine-producing subsets. Generally speaking, the immune
response to a pathogen can develop toward a more
strongly cellular type (type 1), or toward a more allergic type of response (type 2). When well developed,
these gear the immune response for the effective elimination of different types of pathogens, with a type 1
response being more effective against intracellular
pathogens, for example Listeria monocytogenes or
mycobacteria. Type 2 allergic responses, in contrast,
favor the elimination of parasites such as helminths.
The basis for this selective action resides in the
cytokines made by the CD4+ T helper cell subsets in
these responses. T helper type 1 (Th1) cells produce
several characteristic cytokines, most notably IL-2 and
IFN-γ, whereas Th2 cells produce a set of cytokines,
most notably IL-4, IL-5, and IL-13. In turn, IL-2 and
IFN-γ promote the development of strong cell-mediated immunity, whereas the type 2 cytokines promote
allergic responses effective in eliminating parasites.
When confronted with a pathogen, it is important
that the immune system activate the appropriate type
of response. Fortunately, it has developed reliable
mechanisms that help naive CD4 T cells in this choice.
These mechanisms have been fairly well worked out at
many levels over the last decade, and several thorough
reviews have described recent findings regarding the
signaling pathways and transcription factors that contribute to peripheral CD4+ Th development (1–3).
Despite the great progress in the molecular understanding of these processes, there are still issues in this
area that are controversial and actively debated. Here,
we will focus on some aspects that are unresolved within the various models of Th1 and Th2 development
and will try to fit together some of the recent observations that have motivated these somewhat theoretical
considerations. In particular, we will take this opportunity to focus on a difficult topic, that of whether
Th1/Th2 development rests on selective or instructive
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mechanisms, a general issue that is also debated in
regard to CD4/CD8 lineage commitment and is common to many developmental systems. Distinguishing
between strictly selective and instructive models is difficult, as many experimental results can be compatible
with both interpretations.

Cytokines and the Th1/Th2 balance
Cytokines clearly are important in the development of
different cytokine-producing Th1 and Th2 cells. IL-12
secreted by activated macrophages and dendritic cells
promotes Th1 development with IFN-γ secretion (4, 5).
Type I IFNs (IFN-α and -β) also promote Th1 responses in human CD4+ T cells, although they do not appear
to do so efficiently in the mouse (6–9). IL-4, conversely, promotes Th2 development. The source of IL-4 initiating this process is debated (10, 11).
There is little doubt that cytokines at least are very
significant modifiers of Th development, along with
other parameters of activation that can skew development, such as antigen dose or affinity (12). The cellular and molecular steps leading to the polarization in
bulk populations of T cells, in contrast, are not well
understood. Coffman and Reiner have outlined alternative mechanisms that could underlie Th1/Th2
polarization, including a selective cytokine-induced
outgrowth of precommitted T cells, or the instructive
actions of cytokines on naive uncommitted T cell precursors (13). Selective models were initially attractive
because of evidence for cytokine-independent and
Stat-independent phenotype effects (14, 15), as well as
for apparently random, or “stochastic,” aspects of
cytokine gene expression. For example, in some cases,
only one cytokine allele, but not both, is expressed in
Th differentiation (16–18), consistent with a selective
rather than instructive model. Thus, naive T cells may
already be clonally committed to certain fates or may
generate random mixtures of fixed fates upon their
initial stimulation. In either case, the fates here are
fixed, and IL-12 or IL-4 would act by selecting certain
clones for cell survival and growth. These data raised
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the possibility of selection in Th1 and Th2 polarization, but they did not settle the matter, since both
instructive and selective models can accommodate stochastic features of cytokine expression.
The term “stochastic” implies only that there is a
probability associated with gene expression in a cell.
For example, naive CD4+ T cells may have a low, but
non-zero, probability of expressing IL-4, since low
levels of IL-4 can be detected upon strong stimulation of even naive T cells. Both the selective models
can accommodate this observation. Selective models
posit that this is due to the generation of multiple
phenotypes in early rounds of division; instructive
models argue that relatively low levels of Th2-specific transcription factors (e.g., GATA-3) inefficiently
augment IL-4 transcription. Selective and instructive
models are distinguished by the point at which cell
fate commitment is proposed to occur, relative to the
timing of the cytokine effect. In instructive models,
cytokines (e.g., IL-12 or IL-4) are necessary for causing commitment rather than cell outgrowth.
Cytokine signaling induces changes in gene expression, which signifies fate determination. Therefore,
instructive models place cytokines before commitment. By contrast, in selective models, fate commitment precedes cytokines, which only act to alter cell
outgrowth but do not change gene expression within a clonal line.
These differences appear subtle but have fundamentally different implications. Th1/Th2 polarization via instruction implies that the next questions to
answer relate to the changes in transcription factors
and cytokine transcription following cytokine-signaling. Polarization via selection implies we must next
answer how cytokine-signaling can selectively alter
cell survival and growth.

The cell cycle, cell division,
and cytokine gene expression
Reiner and colleagues made the very original and
interesting observation that IL-4 production occurs
at increased frequencies in cells that have undergone
at least three cell divisions (19). Further, they found
that IFN-γ production required at least one round of
cell division. IL-4 production was blocked by
inhibitors that block cells at G1/S and G2/M checkpoints, which they interpreted to indicate that at
least one cell division is required for the initiation of
IL-4 transcription.
Two recent reports build on this observation and
suggest a somewhat different interpretation. Radbruch and colleagues determined that IL-4 induction
occurs in cells that have not progressed through the
first cell division upon T cell activation (20). Here, the
length of exposure to both T cell receptor (TCR) activation and IL-4 signaling was important in commitment to IL-4 synthesis. Similar findings by Paul and
colleagues indicate that both IFN-γ and IL-4 are regulated by the duration of signaling through these
pathways (21). These studies clearly show that in
the first few cell divisions, naive T cells modify cytokine gene chromatin and alter cytokine expression,
432
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findings that are not inconsistent with either selective
or instructive models of development. Since none of
these studies traced individual cell fates, however, it
has not been resolved whether cytokines alter the
probability of gene expression in a clone or induce
selective outgrowth of cells that have randomly committed to a specified fate.

Signaling, transcription, chromatin remodeling,
and fate determination
Reasonable models of differentiation should account
for known effects of signaling pathways and transcription factors on Th1/Th2 development. GATA-3
and T-bet are transcription factors highly, reciprocally induced early on in polarizing conditions. GATA-3
is selectively induced early in Th2 development (22),
induced by IL-4 through Stat6, and inhibited by
IFN-γ and IL-12 through Stat1 and Stat4 (23).
GATA-3 overexpression increases Th2 cytokine expression (22) and inhibits IL-12Rβ2 expression with
decreased Th1 development even in Th1-inducing
conditions (23, 24). GATA-3 induces Th2 development
in Stat6-deficient T cells and induces autoactivation
of the endogenous GATA3 gene (25).
In concordance with instructive models, Th2-specific regulatory elements have been recently identified
within the Th2 cluster. First, Arai and colleagues (26)
identified Th2-specific DNase hypersensitive (HS)
sites between the IL4 and IL13 genes, termed HSS-1
and HSS-2, found later to be within the conserved
noncoding region 1 (CNS-1 region) (27). Other HS
sites were found in IL4 and IL13 genes using similar
approaches but in developing Th2 CD4+ T cells (28),
particularly the intronic enhancer (IE) located in the
first IL4 intron. Ranganath et al. (29) found that
GATA-3 augments enhancer activity of certain genomic regions near IL4 and IL13 in cooperation with the
IL4 promoter. While these authors did not identify
how or where this augmentation occurred, direct evidence that GATA-3 acts at one or both of these sites is
found in the work of Flavell and colleagues (30), who
used transgenic analysis of the IL4 promoter in combinations with various regions including HSS and IE.
In this study, both HSS and IE elements enhanced IL4
promoter activity, but the combination of both when
used in a minilocus showed the greatest level of expression and, more importantly, Th2 specificity. Further,
this minilocus was directly responsive to GATA-3
when introduced by retrovirus into T cells, suggesting
that these sites may represent the places where
GATA-3 acts to begin the process of general activation
of the Th2 cytokine cluster for Th2-specific expression. In addition, Miyatake and colleagues showed
that GATA-3 can directly interact with the CNS-1
region (31). Finally, Mohrs et al. have very recently
shown that the CNS-1 region is definitely required in
the native response of Th2 cytokines to the effects of
IL-4 for Th2 development (32). Together, these studies paint a picture of a Th2 cytokine cluster coordinately controlled by interactions between separated
enhancer-like regions developmentally responsive to
the GATA-3 transcription factor.
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Figure 1
Major pathways thought to regulate the development of T cells with the Th2 phenotype. Th2 cells typically promote allergic symptoms and asthma, as
well as the systemic responses that help combat parasitic responses. As discussed in the text, it is still uncertain whether the effects of various factors are
most consistent with an instructive or a selective route to T cell differentiation. Nevertheless, the transcription factor GATA-3 appears to be central to
this response. Binding of GATA-3 to genes encoding the characteristic Th2 cytokines is an essential first step in the activation of these genes. In addition,
GATA-3 autoactivates its own gene expression, thus stabilizing the Th2 phenotype through an intracellular (intrinsic) positive feedback loop.

How can these observations fit within instructive or
selective models of differentiation? The above studies
suggest an instructive role for GATA-3 in directing
commitment to the Th2 fate and would place
GATA-3 downstream of the effects of cytokine signaling. However, Stat6-independent Th2 development has been observed in vivo and in vitro (33). Since
wild-type levels of GATA-3 are found in Stat6-deficient Th2 cells (25), it seems that the “instructive”
effects of IL-4 signaling can be uncoupled from
GATA-3 expression and Th2 development, implying a
Stat6-independent stochastic process in early commitment. By this thinking, GATA-3 might induce Th2
development through a mechanism that is not
“instructive,” in that GATA-3 expression would not
result from signals delivered by cytokines. Likewise,
overexpression of GATA-3 promotes Th2 development in bulk populations, but this might be due
either to instructive changes in transcriptional programs or to the selective outgrowth of cells already
committed to the Th2 fate. That GATA-3 might
instruct Th2 transcriptional programs was suggested
by its ability to reprogram cytokine expression in previously differentiated cell (34, 35), although these
experiments were not explicitly designed to track individual cell fates. This issue has been tested using
retroviral techniques to tag individual CD4+ T cells
and follow their fate during development. Farrar et al.
(36) found that retrovirus-induced GATA-3 expression in developing clonal progenitors favors commitment to the Th2 fate even in Stat6-deficient T cells.
The finding that GATA-3 expression in this context
induces no apparent selective outgrowth compared
with control retrovirus provides prima facie support
for the instructive rather than the selective model.
The Journal of Clinical Investigation
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GATA-3 regulation through multiple pathways
Besides being induced through Stat6, GATA-3 expression may also be regulated by other signals. For this
reason, the stochastic Th2 commitment observed in
the absence of IL-4 might be due to GATA-3 expression
that was induced through other pathways. GATA-3
appears to activate its own transcription, either directly or indirectly (25, 37), and indeed, a doublet GATAbinding element residing within the first intron of
GATA3 (Figure 1) is required for promoter activity in
reporter assays (38). GATA-3 autoactivation may therefore act as a stabilizing influence in Th2 commitment.
Second, signaling through CD28 augments GATA-3
expression (39). Also, naive CD4+ T cells require NF-κB
p50 activation, presumably downstream of TCR signaling for GATA-3 expression (40). Consistent with
this idea, an NF-κB–binding element is found
upstream of the murine GATA3 transcriptional start
site (40) (Figure 1). CD28-dependent costimulation
augments Th2 responses to infection with Shistosoma
mansoni (41). Finally, a direct link between GATA-3
expression and CD28 signaling was recently proposed
for rat CD4+ T cells (39). Thus, GATA-3 may be controlled by more than simply Stat6 activation, and signals that elevate GATA-3 transiently above its threshold for autoactivation can apparently tip the balance
toward Th2 development.
In summary, for Th2 development, there is strong
evidence that IL-4 acts through Stat6 activation to
elevate GATA-3 transcription. After transient elevation beyond some threshold, GATA-3 autoactivation
occurs, stabilizing its own expression and somehow activating the Th2 cytokine cluster — perhaps
by interactions with sites such as CNS-1 and IE,
increasing promoter accessibility to acutely activated
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transcription factors. Because GATA-3 does not
appear to act by increasing selective cell outgrowth, it
can be said to exert instructive effects. Nonetheless,
there may still be Stat6-dependent mechanisms unrelated to GATA-3 that exert effects on cellular outgrowth, allowing IL-4 and Stat6 to have combined
instructive and selective effects.

Mechanisms in Th1 development
Recently, Glimcher and colleagues (42) found a novel
transcription factor, T-bet, a member of the T-box family of transcription factors that is restricted to Th1 cells
and promotes Th1 development. Initial functional
characterization showed that T-bet is expressed within
24 hours of primary activation under Th1-inducing
conditions. Retroviral overexpression of T-bet in naive
CD4+ T cells increases IFN-γ production and inhibits
Th2 cytokines, even in cells cultured under Th2-inducing conditions. In addition, T-bet appears to regulate
the IFN-γ promoter, suggesting that it directly induces
Th1 fate (42), and may provide the connection between
the signal delivered by IL-12 and Stat4 and the induction of IFN-γ by Th1 cells.
Although Stat4-independent Th1 development in
CD4+ cells has been reported (15, 43), it has been seen
only in the abnormal setting of double deficiency for
both Stat6 and Stat4, and there is significant evidence
that Stat4 activation is required for IFN-γ production
in vivo (44, 45), particularly in CD4+ T cells (14). In
CD8+ T cells, IFN-γ production can occur without
Stat4 (14). Potentially, the use of various modes of
stimulation (TCR, cytokines, or chemical activation)
may involve different requirements for Stat4 in IFN-γ
production or Th1 development.
The initial T-bet study suggested that IL-12 induces
T-bet through Stat4 activation, providing the
instructive link between IL-12 and Th1 development.
However, a more recent study (46) shows that T-bet
is expressed at normal levels in Stat4-deficient T cells.
Importantly, IL-4 inhibits T-bet expression, whereas
retroviral T-bet expression can induce IL-12Rβ2 and
Th1 commitment. These results seem to place T-bet
not downstream of IL-12 and Stat4, but upstream.
Finally, T-bet–expressing cells display increased proliferation, suggesting potentially a selective outgrowth model for T-bet–induced Th1 commitment.
The strong early induction of T-bet in Th1-inducing
conditions, coupled with the normal expression in
Stat4-deficient T cells, suggests that there may be
another pathway controlling its expression, and
indeed, very recent work indicates that T-bet is actually controlled by Stat1, rather than Stat4 (47). To
distinguish selective from instructive models in
T-bet–dependent Th1 development would require
direct cell fate tracking, as has been carried out for
Th2 development (36).
Conclusions
This review has focused on a limited range of issues
within the larger topic of Th1/Th2 regulation. It is
important to note here that selective and instructive
models of differentiation are not mutually exclusive.
434
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Clearly, both IL-12 and IL-4 provide proliferative signals to a variety of cell types. Further, signals delivered through Stat4 and Stat6 can serve dual functions of commitment and selective outgrowth.
Defining their function in these processes is the challenge left in this field.
Th1/Th2 regulation is exceedingly complex, but its
importance is unquestionable, particularly in the
study of such diverse diseases as allergies and asthma,
as well as type 1 diabetes and other autoimmune disorders. This is an active area of research for the
design of immunomodulatory therapies intended
either to dampen overreactive responses or to
strengthen weak ones. Magic bullets and master
switches may be rare commodities in this area.
Nonetheless, defining all of the mechanisms controlling these processes, including the ones discussed
in this review, will help make rational therapies that
manipulate Th1/Th2 balance a reality.
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